Neuropathic Eye Pain Market, Global Outlook and Forecast 2023-2029

Report ID: MMG291138 | Category: Medical Care | Pages: 68 | Format: PDF | Published Date: November 08,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3250.00 Multi User-$4225.00

Report Description
View Table of Contents

Report Summary

The global Neuropathic Eye Pain market was valued at US$ 156.4 million in 2022 and is projected to reach US$ 192.3 million by 2029, at a CAGR of 3.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Steroids Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neuropathic Eye Pain include OKYO Pharma, Ocular Therapeutix, Inc., IACTA Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd, Novartis AG, SALVAT, AbbVie Inc, Bausch &Lomb Incorporated and Kala Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Neuropathic Eye Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuropathic Eye Pain. This report contains market size and forecasts of Neuropathic Eye Pain in global, including the following market information:
Global Neuropathic Eye Pain Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neuropathic Eye Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neuropathic Eye Pain Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Neuropathic Eye Pain Market Segment Percentages, by Type, 2022 (%)
    Steroids
    Antidepressants
    Anticonvulsants
    Opioids
    Others
Global Neuropathic Eye Pain Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Neuropathic Eye Pain Market Segment Percentages, by Application, 2022 (%)
    Clinic
    Hospital
    Others
Global Neuropathic Eye Pain Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Neuropathic Eye Pain Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neuropathic Eye Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Neuropathic Eye Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
    OKYO Pharma
    Ocular Therapeutix, Inc.
    IACTA Pharmaceuticals, Inc.
    Sun Pharmaceutical Industries Ltd
    Novartis AG
    SALVAT
    AbbVie Inc
    Bausch &Lomb Incorporated
    Kala Pharmaceuticals
    Spectra Vision Care
    AlconLaboratories
    BRIM Biotechnology Inc
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neuropathic Eye Pain, market overview.
Chapter 2: Global Neuropathic Eye Pain market size in revenue.
Chapter 3: Detailed analysis of Neuropathic Eye Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neuropathic Eye Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

1 Introduction to Research & Analysis Reports
    1.1 Neuropathic Eye Pain Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Neuropathic Eye Pain Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Neuropathic Eye Pain Overall Market Size
    2.1 Global Neuropathic Eye Pain Market Size: 2022 VS 2029
    2.2 Global Neuropathic Eye Pain Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Neuropathic Eye Pain Players in Global Market
    3.2 Top Global Neuropathic Eye Pain Companies Ranked by Revenue
    3.3 Global Neuropathic Eye Pain Revenue by Companies
    3.4 Top 3 and Top 5 Neuropathic Eye Pain Companies in Global Market, by Revenue in 2022
    3.5 Global Companies Neuropathic Eye Pain Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Neuropathic Eye Pain Players in Global Market
        3.6.1 List of Global Tier 1 Neuropathic Eye Pain Companies
        3.6.2 List of Global Tier 2 and Tier 3 Neuropathic Eye Pain Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Neuropathic Eye Pain Market Size Markets, 2022 & 2029
        4.1.2 Steroids
        4.1.3 Antidepressants
        4.1.4 Anticonvulsants
        4.1.5 Opioids
        4.1.6 Others
    4.2 By Type - Global Neuropathic Eye Pain Revenue & Forecasts
        4.2.1 By Type - Global Neuropathic Eye Pain Revenue, 2018-2023
        4.2.2 By Type - Global Neuropathic Eye Pain Revenue, 2024-2029
        4.2.3 By Type - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Neuropathic Eye Pain Market Size, 2022 & 2029
        5.1.2 Clinic
        5.1.3 Hospital
        5.1.4 Others
    5.2 By Application - Global Neuropathic Eye Pain Revenue & Forecasts
        5.2.1 By Application - Global Neuropathic Eye Pain Revenue, 2018-2023
        5.2.2 By Application - Global Neuropathic Eye Pain Revenue, 2024-2029
        5.2.3 By Application - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global Neuropathic Eye Pain Market Size, 2022 & 2029
    6.2 By Region - Global Neuropathic Eye Pain Revenue & Forecasts
        6.2.1 By Region - Global Neuropathic Eye Pain Revenue, 2018-2023
        6.2.2 By Region - Global Neuropathic Eye Pain Revenue, 2024-2029
        6.2.3 By Region - Global Neuropathic Eye Pain Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America Neuropathic Eye Pain Revenue, 2018-2029
        6.3.2 US Neuropathic Eye Pain Market Size, 2018-2029
        6.3.3 Canada Neuropathic Eye Pain Market Size, 2018-2029
        6.3.4 Mexico Neuropathic Eye Pain Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe Neuropathic Eye Pain Revenue, 2018-2029
        6.4.2 Germany Neuropathic Eye Pain Market Size, 2018-2029
        6.4.3 France Neuropathic Eye Pain Market Size, 2018-2029
        6.4.4 U.K. Neuropathic Eye Pain Market Size, 2018-2029
        6.4.5 Italy Neuropathic Eye Pain Market Size, 2018-2029
        6.4.6 Russia Neuropathic Eye Pain Market Size, 2018-2029
        6.4.7 Nordic Countries Neuropathic Eye Pain Market Size, 2018-2029
        6.4.8 Benelux Neuropathic Eye Pain Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia Neuropathic Eye Pain Revenue, 2018-2029
        6.5.2 China Neuropathic Eye Pain Market Size, 2018-2029
        6.5.3 Japan Neuropathic Eye Pain Market Size, 2018-2029
        6.5.4 South Korea Neuropathic Eye Pain Market Size, 2018-2029
        6.5.5 Southeast Asia Neuropathic Eye Pain Market Size, 2018-2029
        6.5.6 India Neuropathic Eye Pain Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America Neuropathic Eye Pain Revenue, 2018-2029
        6.6.2 Brazil Neuropathic Eye Pain Market Size, 2018-2029
        6.6.3 Argentina Neuropathic Eye Pain Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Neuropathic Eye Pain Revenue, 2018-2029
        6.7.2 Turkey Neuropathic Eye Pain Market Size, 2018-2029
        6.7.3 Israel Neuropathic Eye Pain Market Size, 2018-2029
        6.7.4 Saudi Arabia Neuropathic Eye Pain Market Size, 2018-2029
        6.7.5 UAE Neuropathic Eye Pain Market Size, 2018-2029
7 Neuropathic Eye Pain Companies Profiles
    7.1 OKYO Pharma
        7.1.1 OKYO Pharma Company Summary
        7.1.2 OKYO Pharma Business Overview
        7.1.3 OKYO Pharma Neuropathic Eye Pain Major Product Offerings
        7.1.4 OKYO Pharma Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.1.5 OKYO Pharma Key News & Latest Developments
    7.2 Ocular Therapeutix, Inc.
        7.2.1 Ocular Therapeutix, Inc. Company Summary
        7.2.2 Ocular Therapeutix, Inc. Business Overview
        7.2.3 Ocular Therapeutix, Inc. Neuropathic Eye Pain Major Product Offerings
        7.2.4 Ocular Therapeutix, Inc. Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.2.5 Ocular Therapeutix, Inc. Key News & Latest Developments
    7.3 IACTA Pharmaceuticals, Inc.
        7.3.1 IACTA Pharmaceuticals, Inc. Company Summary
        7.3.2 IACTA Pharmaceuticals, Inc. Business Overview
        7.3.3 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Major Product Offerings
        7.3.4 IACTA Pharmaceuticals, Inc. Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.3.5 IACTA Pharmaceuticals, Inc. Key News & Latest Developments
    7.4 Sun Pharmaceutical Industries Ltd
        7.4.1 Sun Pharmaceutical Industries Ltd Company Summary
        7.4.2 Sun Pharmaceutical Industries Ltd Business Overview
        7.4.3 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Major Product Offerings
        7.4.4 Sun Pharmaceutical Industries Ltd Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.4.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
    7.5 Novartis AG
        7.5.1 Novartis AG Company Summary
        7.5.2 Novartis AG Business Overview
        7.5.3 Novartis AG Neuropathic Eye Pain Major Product Offerings
        7.5.4 Novartis AG Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.5.5 Novartis AG Key News & Latest Developments
    7.6 SALVAT
        7.6.1 SALVAT Company Summary
        7.6.2 SALVAT Business Overview
        7.6.3 SALVAT Neuropathic Eye Pain Major Product Offerings
        7.6.4 SALVAT Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.6.5 SALVAT Key News & Latest Developments
    7.7 AbbVie Inc
        7.7.1 AbbVie Inc Company Summary
        7.7.2 AbbVie Inc Business Overview
        7.7.3 AbbVie Inc Neuropathic Eye Pain Major Product Offerings
        7.7.4 AbbVie Inc Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.7.5 AbbVie Inc Key News & Latest Developments
    7.8 Bausch &Lomb Incorporated
        7.8.1 Bausch &Lomb Incorporated Company Summary
        7.8.2 Bausch &Lomb Incorporated Business Overview
        7.8.3 Bausch &Lomb Incorporated Neuropathic Eye Pain Major Product Offerings
        7.8.4 Bausch &Lomb Incorporated Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.8.5 Bausch &Lomb Incorporated Key News & Latest Developments
    7.9 Kala Pharmaceuticals
        7.9.1 Kala Pharmaceuticals Company Summary
        7.9.2 Kala Pharmaceuticals Business Overview
        7.9.3 Kala Pharmaceuticals Neuropathic Eye Pain Major Product Offerings
        7.9.4 Kala Pharmaceuticals Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.9.5 Kala Pharmaceuticals Key News & Latest Developments
    7.10 Spectra Vision Care
        7.10.1 Spectra Vision Care Company Summary
        7.10.2 Spectra Vision Care Business Overview
        7.10.3 Spectra Vision Care Neuropathic Eye Pain Major Product Offerings
        7.10.4 Spectra Vision Care Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.10.5 Spectra Vision Care Key News & Latest Developments
    7.11 AlconLaboratories
        7.11.1 AlconLaboratories Company Summary
        7.11.2 AlconLaboratories Business Overview
        7.11.3 AlconLaboratories Neuropathic Eye Pain Major Product Offerings
        7.11.4 AlconLaboratories Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.11.5 AlconLaboratories Key News & Latest Developments
    7.12 BRIM Biotechnology Inc
        7.12.1 BRIM Biotechnology Inc Company Summary
        7.12.2 BRIM Biotechnology Inc Business Overview
        7.12.3 BRIM Biotechnology Inc Neuropathic Eye Pain Major Product Offerings
        7.12.4 BRIM Biotechnology Inc Neuropathic Eye Pain Revenue in Global Market (2018-2023)
        7.12.5 BRIM Biotechnology Inc Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Neuropathic Eye Pain Market, Global Outlook and Forecast 2023-2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?